Call Options

8 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$2.7 - $7.62 $38,070 - $107,442
-14,100 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$6.3 - $8.84 $410,130 - $575,484
-65,100 Reduced 82.2%
14,100 $100,000
Q4 2021

Feb 15, 2022

BUY
$6.02 - $11.43 $176,386 - $334,899
29,300 Added 58.72%
79,200 $660,000
Q3 2021

Nov 16, 2021

SELL
$5.46 - $22.6 $521,976 - $2.16 Million
-95,600 Reduced 65.7%
49,900 $347,000
Q2 2021

Aug 16, 2021

BUY
$18.46 - $24.36 $173,524 - $228,984
9,400 Added 6.91%
145,500 $3.47 Million
Q1 2021

May 18, 2021

BUY
$17.66 - $28.92 $1.05 Million - $1.71 Million
59,200 Added 76.98%
136,100 $2.8 Million
Q4 2020

Feb 17, 2021

BUY
$23.25 - $37.73 $378,975 - $614,999
16,300 Added 26.9%
76,900 $1.88 Million
Q3 2020

Nov 17, 2020

BUY
$3.74 - $28.74 $226,644 - $1.74 Million
60,600 New
60,600 $1.72 Million

Others Institutions Holding MCRB

About Seres Therapeutics, Inc.


  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $114M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.